Hypothesis

Chronic JNK/AP-1 activation in senescent cells does not merely increase autophagy initiation; it actively blocks autophagosome‑lysosome fusion by sustaining GSK-3β‑mediated phosphorylation of the SNARE protein VAMP8, thereby trapping cells in a toxic autophagy‑intermediate state.

Rationale

The data show that JNK/AP-1 drives autophagy gene transcription while flux is incomplete, and that mTORC1 remains active despite starvation. We propose that JNK/AP-1 up‑regulates GSK-3β activity (or inhibits its inhibitory phosphorylation) leading to increased GSK-3β‑dependent phosphorylation of VAMP8 at Ser120, a modification known to reduce its SNARE complex formation and impair fusion. This creates a feed‑forward loop: stalled autophagosomes accumulate, generating additional ROS that further activate JNK. Importantly, this mechanism operates downstream of transcription, consistent with the lack of direct AP-1 repression of ATG genes.

Testable Predictions

1. Senescent cells will exhibit elevated phospho‑VAMP8 (Ser120) levels that correlate with LC3‑II accumulation and reduced colocalization with lysosomal LAMP1.
2. Pharmacological inhibition of GSK-3β (e.g., CHIR99021) or expression of a non‑phosphorylatable VAMP8‑S120A mutant will restore autophagic flux and decrease senescence markers without altering autophagy gene expression.
3. JNK inhibition will lower GSK-3β activity and phospho‑VAMP8, rescuing fusion, whereas overexpression of a constitutively active GSK-3β will mimic the JNK‑induced block even in young cells.

Experimental Approach

• Model: Use irradiated human fibroblasts and aged mouse cochlear explants as senescent models.
• Readouts: Western blot for phospho‑VAMP8 (Ser120), LC3‑II/p62 turnover with bafilomycin A1, immunofluorescence for LC3 and LAMP1 colocalization, senescence‑associated β‑galactosidase, and SASP cytokine ELISA.
• Interventions: (a) JNK inhibitor SP600125, (b) GSK-3β inhibitor CHIR99021, (c) siRNA against VAMP8, (d) transfection of VAMP8‑S120A or VAMP8‑S120D phosphomimetic.
• Analysis: Compare flux (LC3‑II change with/without bafilomycin) and fusion efficiency across conditions; assess cell viability to confirm selective toxicity of flux restoration in senescent versus proliferative cells.

Potential Implications

If validated, this model reframes autophagy dysregulation in aging as a kinase‑driven blockade of a late step, suggesting that combined JNK/GSK-3β inhibition could selectively clear senescent cells by completing autophagy, offering a therapeutic avenue distinct from generic autophagy inducers or inhibitors.

All cited works: 1, 2, 3, 4, 5, 6, 7.